Drugs with structural defense against biosimilar/generic competition: #1 Krystexxa Posted by By biotechwarrior January 30, 2022Posted inTalking about BiotechNo Comments As an investor, you are always looking for a company with sustainable moat - a moat that can be preserved over time and a moat that can become stronger over…